Lyudmila Lazareva

Ms. Lyudmila Lazareva

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Larisa SuturinaLarisa Suturina
Larisa Suturina
DLDaria Lizneva
Daria Lizneva
AAAlina Atalyan
Alina Atalyan
LLLyudmila Lazareva
Lyudmila Lazareva
ABAleksey Belskikh
Aleksey Belskikh
RARicardo Azziz
Ricardo Azziz
Androgen assessment is a key element for diagnosing polycystic ovary syndrome (PCOS), and defining a “normal” level of circulating androgens is critical for epidemiological studies. We determined the upper normal limits (UNLs) for androgens in a population-based group of premenopausal “healthy control” women, overall and by ethnicity (Caucasian and Asian), in the cross-sectional Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (ClinicalTrials.gov ID: NCT05194384) conducted in 2016–2019. Overall, we identified a “healthy control” group consisting of 143 healthy premenopausal women without menstrual dysfunction, hirsutism, polycystic ovaries, or medical disorders. We analyzed serum total testosterone (TT) by using liquid chromatography with tandem mass spectrometry (LC-MS/MS), and DHEAS, sex-hormone-binding globulin (SHBG), TSH, prolactin, and 17-hydroxyprogesterone (17OHP) were assessed with an enzyme-linked immunosorbent assay (ELISA). The UNLs for the entire population for the TT, free androgen index (FAI), and DHEAS were determined as the 98th percentiles in healthy controls as follows: 67.3 (95% confidence interval (CI): 48.1, 76.5) ng/dl, 5.4 (3.5, 14.0), and 355 (289, 371) μg/dl, respectively. The study results demonstrated that the UNLs for TT and FAI varied by ethnicity, whereas the DHEAS UNLs were comparable in the ethnicities studied.

4 July 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Larisa SuturinaLarisa Suturina
Larisa Suturina
ESEldar M. Sharifulin
Eldar M. Sharifulin
MSMaharam A. Sharifulin
Maharam A. Sharifulin
LLLyudmila Lazareva
Lyudmila Lazareva
IDIrina Nikolaevna Danusevich
Irina Nikolaevna Danusevich
INIana Gennadievna Nadeliaeva
Iana Gennadievna Nadeliaeva
Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of virilization, which has an erased picture in postmenopausal women. LCTs require differential diagnosis with other causes of hyperandrogenism. We present the clinical case of a 55-year-old Russian postmenopausal patient with LCTs of the right ovary, significantly increased levels of androgens, and rapidly progressive clinical signs of hyperandrogenism. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the androgen indices reached average values by the first and third month after surgery. This case demonstrates that LCTs are often benign with a good prognosis and normalization of the clinical and laboratory manifestations of hyperandrogenism after surgical treatment. The type of surgery performed (bilateral salpingo-oophorectomy rather than unilateral) is recommended as the treatment of choice for LCTs in postmenopausal patients.

1 January 2020 in Doctor.Ru
Verified
Journal Article
Open access
LLLyudmila Lazareva
Lyudmila Lazareva
RIRussian Federation Irkutsk
Russian Federation Irkutsk
ESE.M. Sharifulin
E.M. Sharifulin
LBL.V. Belenkaya
L.V. Belenkaya
Larisa SuturinaLarisa Suturina
Larisa Suturina
СПКЯ в репродуктивном возрасте: фенотипическое разнообразие и диагностические подходы (обзор литературы)

29 December 2022 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
Larisa SuturinaLarisa Suturina
Larisa Suturina
ABA. V. Belskikh
A. V. Belskikh
LSL. F. Sholokhov
L. F. Sholokhov
MRM. A. Rashidova
M. A. Rashidova
IDIrina Nikolaevna Danusevich
Irina Nikolaevna Danusevich
ЯНЯ. Г. Наделяева
Я. Г. Наделяева
Testosterone assessment is essential for detecting biochemical hyperandrogenism, one of the important diagnostic criteria of polycystic ovary syndrome (PCOS) both in clinical practice and in epidemiological studies. Currently, tandem liquid chromatography-mass spectrometry (LC-MS/MS) is the most preferred technique to measure testosterone level in women. Its validation is important to reproducibility of androgen tests results for clinical practice and for epidemiological studies of the prevalence PCOS.The aim of the study. To develop and validate a method for determining total testosterone in blood serum using highly efficient LC-MS/MS to assess androgenemia in the epidemiological study of the prevalence of PCOS and its phenotypes in Eastern Siberia (ESPEP STUDY).Materials and methods. We determined a total testosterone level in serum blood using triple quadrupole mass spectrometer LCMS-8060 (Shimadzu, Japan). The protocol of technique was developed using self-prepared purified human testosteronefree serum with a known concentration of analyzed compound. We used the serum samples of women of reproductive age to test the developed method.Results. Optimum chromatographic conditions were obtained with a Kromasil 100-2.5-C18 column (2.1 mm × 100 mm; AkzoNobel, Netherlands), and an isocratic elution mode using a mobile phase consisting of acetonitrile and 0.1 % aqueous solution of formic acid. The total flow rate was 0.35 ml/min. The lower limit of quantification was 5 ng/dl with an average accuracy of 100.2 %. During the approbation of the method in a test population sample of 1138 premenopausal women (mean age – 34.3 ± 6.3 years), the median testosterone concentration was 26.9 ng/dl.Conclusion. It was found that the proposed method for determining testosterone in blood serum has acceptable linearity and reproducibility and meets the requirements for bioanalytical methods under the regulatory documentation. This method can be used for clinical practice and epidemiological study of the prevalence of PCOS.

1 January 2022 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
LLLyudmila Lazareva
Lyudmila Lazareva
LBL.V. Belenkaya
L.V. Belenkaya
Larisa SuturinaLarisa Suturina
Larisa Suturina
The regular menstrual cycle is one of the key health indicators in women of reproductive age, while its disorders most often demonstrate the presence of ovarian dysfunction (OD). Women with OD are at risk of infertility, adverse pregnancy outcomes, carbohydrate metabolism disorders, cardiovascular diseases, osteoporosis, and oncopathology. The aim of this review was to systematize the current data on the prevalence, clinical forms, and methods of diagnosis of OD. OD is very common in the female population, has a complex etiopathogenesis, is one of the symptoms of serious endocrinopathies, genetic disorders, and is a frequent cause of infertility. The main types of OD are oligo/anovulation (OA) and luteal phase deficiency (LPD). Depending on the nature of hormonal disorders, hypogonadotropic, normogonadotropic, hypergonadotropic OD and OD against the background of hyperprolactinemia are distinguished. Clinical manifestations of OD include oligo/amenorrhea, abnormal uterine bleeding and may have a subclinical course without menstrual irregularities. The diagnosis of OD is a challenging task that requires a thorough collection of menstrual history, determination of serum progesterone levels in the luteal phase, evaluation of instrumental examination results. Differential diagnosis of OD is necessary for detecting the clinical form of OD and should be based on the use of modern clinical protocols and standardized algorithms. Key words: ovarian dysfunction, oligo/anovulation, oligo/amenorrhea, menstrual disorders, luteal phase deficiency

29 September 2023 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
LBL. V. Belenkaia
L. V. Belenkaia
Larisa SuturinaLarisa Suturina
Larisa Suturina
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
AAAlina Atalyan
Alina Atalyan
LLLyudmila Lazareva
Lyudmila Lazareva
ЯНЯ. Г. Наделяева
Я. Г. Наделяева
The aim of the study. To determine the age limit of the initial manifestations of the metabolic syndrome in women of reproductive age of the Caucasian and Asian ethnic groups. Materials and methods. The study included women of reproductive age of the Russian and Buryat ethnic groups (n = 1231). We carried out general clinical examination, studied glycemia levels and lipid metabolism indicators. The analysis of the components of the metabolic syndrome was performed taking into account age characteristics and ethnicity. Threshold values for the age of metabolic disorders manifestation were determined. Results. It was found that the main components of the metabolic syndrome in women of reproductive age of the Russian and Buryat ethnic groups were a decrease in high-density lipoprotein (HDL), an increase in waist circumference, and an increase in blood pressure. The age-related determinants of the metabolic syndrome in the population of women of reproductive age in the Baikal region were determined. It was shown that the age-related determinants of the metabolic syndrome in Caucasian and Asian women do not differ significantly and amount to 33.5 years (95% confidence interval (95% CI): 32.5; 38.5) and 36.5 years (95% CI: 27.5; 52.5), respectively. A universal critical age value was determined as 34.5 years (95% CI: 32.5; 38.5), which is associated with a significant increase in the prevalence of the metabolic syndrome in accordance with the ATP III criteria. The ranking of metabolic syndrome criteria in the studied groups revealed the following order of their occurrence: the decrease in HDL index prevailed, followed by the increase in waist circumference, blood pressure, glucose and triglycerides; no dependence on the ethnicity was found. Conclusion. When assessing the age-related determinants of the metabolic syndrome in the mixed Caucasoid-Asian group, it is advisable to use universal approaches, taking into account the cut-off point of age, which is 34.5 years. The determination of age criteria for the correct classification of patients with respect to the manifestations of the metabolic syndrome is necessary to analyze the contribution of the age factor to the implementation of various metabolic syndrome predictors, to develop prognostic models, and to use effective age-determined markers of metabolic disorders.